Literature DB >> 2468712

Human insulin autoantibody fine specificity and H and L chain use.

L J Nell1, C Hulbert, J W Thomas.   

Abstract

Fine specificity and H and L chain isotypes of insulin autoantibodies in sera from 11 subjects were examined. None of these 11 subjects was treated with exogenous insulin. Two patterns of fine specificity were found. In one, the autoantibodies were specific for human insulin, with a requirement for threonine at B30. The conservative substitution in pork insulin (threonine to alanine) abrogated IgG binding by these sera. Insulin autoantibodies in other sera cross-reacted with beef, pork, and human insulin; not requiring threonine at B30. Reciprocal competitive inhibition experiments showed that epitopes recognized by the human specific insulin autoantibodies were exclusively on the B chain, whereas the cross-reactive sera contain autoantibodies that recognize both the B chain and combinatorial (A and B chain) epitopes. The fine specificity of cross-reactive insulin autoantibodies are thus similar to insulin antibodies from insulin-treated subjects. When IgG subclasses and L chains of insulin autoantibodies were examined, however, restricted C region usage was found. The hierarchy was IgG3 greater than G1 greater than G2 greater than G4; with one subclass dominant in each serum, although others were used. L chain use was similarly restricted. There was no correlation between isotype and fine specificity or between H and L chain type. It is concluded that heterogeneity of insulin autoantibodies is restricted. The response is probably more oligo- or pauciclonal than insulin antibody from insulin-treated subjects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468712

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Antigen-specific responses in autoimmunity and tolerance.

Authors:  J W Thomas
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome.

Authors:  P Bini; J L Chu; C Okolo; K Elkon
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Polymorphism of insulin antibodies in six patients with insulin-immune hypoglycaemic syndrome.

Authors:  N Dozio; F Sodoyez-Goffaux; M Koch; B Ziegler; J C Sodoyez
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

4.  Clonally restricted insulin autoantibodies in a cohort of 2200 healthy blood donors.

Authors:  J C Sodoyez; F Sodoyez-Goffaux; M Koch; D Sondag; C Bouillenne; C François-Gérard; E Bosi
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

5.  The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes.

Authors:  D Devendra; T S Galloway; S J Horton; A Evenden; U Keller; T J Wilkin
Journal:  Diabetologia       Date:  2003-06-03       Impact factor: 10.122

6.  Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes status.

Authors:  Bernice Lo; Austin D E Swafford; Kimberly A Shafer-Weaver; Lawrence F Jerome; Luba Rakhlin; Douglas R Mathern; Conor A Callahan; Ping Jiang; Lucy J Davison; Helen E Stevens; Carrie L Lucas; Jill White; Reid von Borstel; John A Todd; Michael J Lenardo
Journal:  J Transl Med       Date:  2011-11-28       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.